We conduct scientific & medical literature evaluations for clients of the biopharmaceutical industry ... that the zetomipzomib Investigational New Drug (IND) application for the treatment of lupus ...

intended for treating lupus nephritis (LN). The decision follows Kezar's voluntary suspension of enrollment and dosing in the Phase 2b PALIZADE clinical trial for active LN, based on the ...

(Nasdaq: KZR), a clinical-stage biotechnology company developing a novel small molecule to treat unmet needs in immune-mediated diseases, today announced that it was informed via teleconference with ...

application for the treatment of lupus nephritis (LN) has been placed on clinical hold. This action follows Kezar’s communication to the FDA that Kezar was voluntarily suspending enrollment and ...

Panelists discuss the goals of therapy for lupus nephritis (LN), emphasizing the urgency of treatment to prevent renal flares and the consequences of untreated LN, as well as strategies for ...

Panelists discuss the updated treatment recommendations for lupus nephritis in the Kidney Disease Improving Global Outcomes and European Alliance of Associations for Rheumatology guidelines ...

BALTIMORE — Three different versions of Alexandria Wingate appear in a trio of purple paintings the Baltimorean started while a fine art student ... Lupus can cause damage in any organ in the body ...

including the severity of lupus symptoms a person is experiencing, their emotional well-being, any co-existing medical conditions, and cognitive dysfunction. The pain and overall reduction in ...

Lupkynis (voclosporin) is now approved in Japan to treat lupus nephritis, a complication of lupus marked by kidney damage and inflammation. The Japanese Ministry of Health, Labour, and Welfare ...

But few have explained how they will effectively enforce them. University of Pittsburgh students Asher Goodwin and Ilan Gordon were walking to the first Shabbat service of the school year on Aug.